Cargando…
Evaluation of serum cyfra21 in patients with pleural effusion
BACKGROUND: The aim of this study is to determine the level of serum cytokeratin19 fragment (cyfra21-1) in patients with benign or malignant pleural effusion and evaluation the sensitivity and specificity of this tumor marker. METHOD & MATERIAL: We prospectively evaluated 98 patients (39 maligna...
Autores principales: | Azimi, Q, Rezadoost, B, Jalali Nadoushan, M, Davati, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518977/ https://www.ncbi.nlm.nih.gov/pubmed/23285412 |
Ejemplares similares
-
Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
por: Salama, G., et al.
Publicado: (1998) -
Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion
por: Xu, Zhiyang, et al.
Publicado: (2022) -
Differential diagnostic CYFRA 21-1 level for benign and malignant pleural effusions: a meta-analysis in the Chinese population
por: Biaoxue, Rong, et al.
Publicado: (2012) -
Clinical significance of serum CYFRA 21-1 in gastric cancer.
por: Nakata, B., et al.
Publicado: (1996) -
Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
por: Jeiroodi, Naghmeh, et al.
Publicado: (2017)